Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2016
Day Zero Diagnostics is revolutionizing infectious disease diagnostics through rapid, whole genome sequencing-based technologies that provide same-day identification and antimicrobial susceptibility testing from clinical samples. Their innovative approach addresses the critical issue of antibiotic resistance by delivering clinically actionable data in hours rather than days, empowering physicians to make informed treatment decisions and improve patient outcomes. With a focus on bloodstream infections and sepsis, Day Zero's solutions aim to transform the standard of care in infectious disease management, leveraging machine learning algorithms and a comprehensive database of genomic data to enhance precision medicine. The company is positioned to meet a significant unmet clinical need in the healthcare market, particularly in the context of rising antibiotic resistance and the urgent demand for rapid diagnostics.
Something looks off?